Cohort characteristics with sebaceous gland carcinoma
| Clinical features | |
| Age (years) | 65.4 (42.1–93.7) |
| Gender | |
| Female | 16 (72.7%) |
| Male | 6 (27.3%) |
| Laterality | |
| Right | 10 (45.4%) |
| Left | 12 (54.5%) |
| Location | |
| Upper lid | 19 (86.3%) |
| Lower lid | 3 (13.6%) |
| Tumour stage | |
| T2a (>5 to ≤10 mm) | 16 (72.7%) |
| T2b (>10 to ≤20 mm) | 3 (13.6%) |
| T3a (>20 mm) | 2 (9.1%) |
| T3b (complete resection requires exenteration, enucleation) | 1 (4.5%) |
| Presentation | |
| Nodular | 20 (90.9%) |
| Blepharitis | 2 (9.1%) |
| Management | |
| Local excision+reconstruction | 19 (86.4%) |
| Local excision+reconstruction+mitomycin-C | 1 (4.5%) |
| Orbital exenteration | 2 (9.1%) |
| Time to presentation (years) | 1.03 (0.04–6.0) |
| Follow-up (years) | 5.76 (0.61–13.1) |